Adropin a candidate diagnostic biomarker for cardiovascular disease in patients with chronic kidney disease
Particularly in CKD patients, adropin may be a useful biomarker for predicting the onset of CVD. Adropin may represent a novel and useful blood marker for assessing systolic function and Spontaneous coronary artery dissection (SCAD).
Authors
- Moushira Zaki (ORCID: https://orcid.org/0000-0002-5853-0050)
- Eman R. Youness (ORCID: https://orcid.org/0000-0002-6492-1680)
- Hend Mohamed Tawfik
- Maha Abd El Moneem Elfedawy
- Samia Abd El Sadek Elsebai
Institutions
- Al-Azhar University (EG)
- National Research Centre (EG)
- Al Azhar University (QA)
Publication Details
- Journal
- Journal of Genetic Engineering and Biotechnology
- Published
- 2024-11-20
- DOI
- https://doi.org/10.1016/j.jgeb.2024.100438
- Citations
- 5
- Primary Topic
- Adipose Tissue and Metabolism
- Type
- article
- Field-Weighted Citation Impact
- 1.63